Answers are grounded in this paper and cite their sources.
Recently, clinical evidence has raised BMI as an emerging prognostic factor for immunotherapy, regardless of cancer types "
No takes yet. Share an insight, caveat, or question.
Gelibter et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: